BPC-157 / TB-500 / GHK-Cu / KPV

Quantity

Clear

Certificate of Analysis

Third-party tested for 99% purity, ID, quantity.

Certificate of Analysis

Third-party tested for endotoxins

80 mg

Four-component synthetic peptide blend. Reference material for in vitro laboratory research use only.

Component Details

Component	Fill	CAS	MW
BPC-157	10 mg	137525-51-0	1419.5
TB-500	10 mg	885340-08-9	889.01
GHK-Cu	50 mg	89030-95-5	401.9
KPV	10 mg	67727-97-3	342.44

Net content

80 mg per vial (gross fill; actual content per lot COA)

Form

Lyophilized powder

Storage

?20 °C, desiccated, protected from light

Testing

Identity and purity verified by third-party HPLC analysis; a lot-specific Certificate of Analysis is provided with each order.

Research Use Only. Not a drug, supplement, or food. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease.

BPC-157 / TB-500 / GHK-Cu / KPV Structure

Molecular Formula: C??H??CuN?O?
Molecular Weight: 340.9 g/mol
PubChem ID: 5311476
------------------------
Molecular Formula: C??H??CuN?O?
Molecular Weight: 340.9 g/mol
PubChem ID: 5311476
------------------------
Molecular Formula: C???H???N??O??S
Molecular Weight: 4963.5 g/mol
PubChem ID: 16132321
--------------------------
Formula: C??H??N?O?
Molecular Weight: 388.4 g/mol
PubChem ID: 16129619

Research Findings

The KLOW Blend, which combines GHK-Cu, BPC-157, TB-500, and KPV, has been studied in structural, vascular, epithelial, and systemic models. Research highlights activity in collagen formation, extracellular matrix remodeling, angiogenesis, molecular migration, and cytokine modulation. The inclusion of KPV further supports immune signaling and cytokine-modulating pathways, expanding the experimental scope of this blend in preclinical settings.

Key Areas of Research:

Structural: Collagen, matrix, connective signaling
Vascular: Angiogenesis, nitric oxide, remodeling
Epithelial: Migration, matrix signaling, follicle dynamics
Systemic: Cytokine modulation, immune signaling, pathway dynamics

Together, these findings suggest broad experimental potential for the KLOW Blend across multiple biological pathways. By combining structural support, vascular and epithelial activity, and immune signaling, the KLOW Blend provides a versatile platform for research into molecular dynamics, matrix characterization, and systemic resilience in laboratory settings.

Sikiric P. et al., 2020

References

Pickart L. et al. (2015). GHK-Cu and regulation of multiple biological processes in aging and repair. BioMed Res Int.

Sikiric P. et al. (1993). A new gastric peptide, BPC-157, characterized and synthesized. Peptides, 14(1):127–131.

Goldstein A.L. et al. (2005). Thymosin beta-4 and tissue regeneration: potential mechanisms of action. Ann N Y Acad Sci.

Maquart F.X. et al. (1988). Stimulation of collagen synthesis by the tripeptide GHK in fibroblast cultures. FEBS Lett, 238(2):343–346.

Japjec M. et al. (2021). BPC-157 and tendon/ligament structural integrity in experimental models. Int J Mol Sci, 22(17):9397.

Smart N. et al. (2007). Thymosin beta-4 induces progenitor mobilization and neovascularization. Nature, 445(7124):177–182.

Seiwert S. et al. (2018). Angiogenic activity and NO-system modulation by BPC-157 in laboratory models. J Vasc Res, 55(3):155–163.

Philp D. et al. (2003). Thymosin beta-4 promotes dermal wound healing. J Invest Dermatol, 121(4):694–701.

Hsieh M.J. et al. (2014). Pro-angiogenic and reparative effects of BPC-157 in preclinical models. J Mol Med, 92(5):483–495.

Moss J. et al. (2020). Anti-inflammatory properties of the tripeptide KPV in epithelial and systemic models. Int J Pept Res Ther, 26:1037–1046.

Kang E.A. et al. (2020). BPC-157 protective effects on liver, kidney, and lung in ischemia–reperfusion injury. Int J Mol Sci, 21(12):4232.

Our Process

STEP 1

Precision Lyophilization

Manufactured in a controlled U.S. facility under strict compounding standards.

STEP 2

Verified Purity

Every batch third-party tested with HPLC and mass spectrometry.

STEP 3

Same-Day Fulfillment

Orders dispatched same-day from our
U.S. facility.

STEP 1

Precision Lyophilization

Manufactured in a controlled U.S. facility under strict compounding standards.

STEP 2

Verified Purity

Every batch third-party tested with HPLC and mass spectrometry.

STEP 3

Same-Day Fulfillment

Orders dispatched same-day from our
U.S. facility.

Email us, our dedicated team is here to help

Reach out and get a response within minutes.

Frequently Asked Questions

Everything you need to know about our products and processes.

What's the actual amount in each vial?

Each vial contains exactly what’s shown on the label. For example, a 10mg vial has exactly 10mg of lyophilized peptide. Researchers can divide it into smaller portions—like four 2.5mg measurements—but the total amount remains 10mg.

Are additional supplies needed?

Peptides are supplied as lyophilized powder. They do not come reconstituted, and any extra supplies must be sourced separately for research applications.

How long does a vial last?

In lyophilized powder form, peptides stay stable for up to 2 years. After reconstitution, it should be refrigerated and is generally stable for up to 2 months.

Does the product come with instructions?

Products from us do not include usage instructions, as they are strictly for in vitro research and prohibited by law for human or animal use. Misuse or unlawful application will result in permanent denial of service.

How should I store these products?

Lyophilized peptides should be stored away from heat and light. Once reconstituted, they must be refrigerated to maintain stability and efficacy.